Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

被引：0
|
作者：
J. Braun
H. Haibel
M. de Hooge
R. Landewé
M. Rudwaleit
T. Fox
A. Readie
H. B. Richards
B. Porter
R. Martin
D. Poddubnyy
J. Sieper
D. van der Heijde
机构：
[1] Rheumazentrum Herne,VIB Inflammation Research Center
[2] Charité Universitätsmedizin Berlin,undefined
[3] Ghent University,undefined
[4] Maastricht University Medical Center,undefined
[5] Klinikum Bielefeld,undefined
[6] Novartis Pharma AG,undefined
[7] Novartis Pharmaceuticals Corporation,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Ankylosing spondylitis; Radiographic progression; Interleukin-17A; Secukinumab; Retrospective cohort study; Biologic therapy; Nonsteroidal anti-inflammatory drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients in Malaysia
    Ong, Ping Seung
    Nur-Aida-Sabrina, Mohd R.
    Haziqah-Itqan, Alias
    Lau, Ing S.
    Mollyza, Mohd Z.
    Azmillah, Rosman
    Tan, Bee E.
    Lim, Ai Lee
    Shahrazat, Hamad N.
    Teh, Cheng L.
    Ling, Guo R.
    Eleen, Chong Y. Y.
    Wahinuddin, Sulaiman
    Gun, Suk C.
    Heselynn, Hussein
    Shuhaila, Shahril N.
    Liza, Mohd, I
    Chong, Hwee C.
    Loh, Yet L.
    Ruhaila, Abd Rahim
    Shuhaida, Ahmad M.
    Asmahan, Mohamed I.
    Asmah, Mohd
    Hilmi, Abdullah
    Fariz, Yahya
    Gan, Syang P.
    Tan, Lay K.
    Mar-Chinniah, Sanjay
    Aain, Ahmad F. Nurul
    Salsabil, Sulaiman
    Too, Chun L.
    EGYPTIAN RHEUMATOLOGIST, 2022, 44 (04) : 357 - 360
  • [22] Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Machado, Pedro M.
    Gensler, Lianne S.
    Marzo-Ortega, Helena
    Sherif, Bintu
    Quebe-Fehling, Erhard
    Porter, Brian
    Gaillez, Corine
    Deodhar, Atul
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 273 - 288
  • [23] The European Ankylosing Spondylitis Infliximab Cohort (EASIC): a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
    Heldmann, F.
    Brandt, J.
    van der Horst-Bruinsma, I. E.
    Landewe, R.
    Sieper, J.
    Burmester, G. R.
    van den Bosch, F.
    de Vlam, K.
    Geusens, P.
    Gaston, H.
    Schewe, S.
    Appelboom, T.
    Emery, P.
    Dougados, M.
    Leirisalo-Repo, M.
    Breban, M.
    Listing, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 672 - 680
  • [24] Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial
    Hartl, Agnes
    Sieper, Joachim
    Syrbe, Uta
    Listing, Joachim
    Hermann, Kay-Geert
    Rudwaleit, Martin
    Poddubnyy, Denis
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [25] Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial
    Agnes Hartl
    Joachim Sieper
    Uta Syrbe
    Joachim Listing
    Kay-Geert Hermann
    Martin Rudwaleit
    Denis Poddubnyy
    Arthritis Research & Therapy, 19
  • [26] TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
    Molnar, Christoph
    Scherer, Almut
    Baraliakos, Xenofon
    de Hooge, Manouk
    Micheroli, Raphael
    Exer, Pascale
    Kissling, Rudolf O.
    Tamborrini, Giorgio
    Wildi, Lukas M.
    Nissen, Michael J.
    Zufferey, Pascal
    Bernhard, Jurg
    Weber, Ulrich
    Landewe, Robert B. M.
    van der Heijde, Desiree
    Ciurea, Adrian
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) : 63 - 69
  • [27] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Bounas, Andreas
    Gullick, Nicola
    Lespessailles, Eric
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1129 - 1142
  • [28] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Uta Kiltz
    Petros P. Sfikakis
    Karl Gaffney
    Andreas Bounas
    Nicola Gullick
    Eric Lespessailles
    Jan Brandt-Juergens
    Rasho Rashkov
    Barbara Schulz
    Effie Pournara
    Piotr Jagiello
    Rheumatology and Therapy, 2022, 9 : 1129 - 1142
  • [29] The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
    Nam, Bora
    San Koo, Bon
    Choi, Nayeon
    Shin, Ji-Hui
    Lee, Seunghun
    Bin Joo, Kyung
    Kim, Tae-Hwan
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Magnetic resonance imaging assessment of spinal inflammation in patients treated for Ankylosing spondylitis
    Treitl, Marcus
    Korner, Markus
    Becker-Gaab, Christa
    Tryzna, Malte
    Rieger, Johannes
    Pfeifer, Klaus-Juergen
    Reiser, Maximilian F.
    Wirth, Stefan
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (01) : 126 - 136
12345